shutterstock_1528056221_jhvephoto

JHVEphoto / Shutterstock.com

23 September 2021AmericasAlex Baldwin

PTAB affirms validity of three Medtronic patents in Axonics suit

The US Patent Trial and Appeal Board (PTAB) has confirmed the validity of three remaining Medtronic patents challenged by rival medical device manufacturer Axonics.

Already registered?

Login to your account

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Medtronic unit to pay $106.5 million in heart valve feud

9 February 2023 Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid.

Split Fed Cir refutes Medtronic challenge to catheter patents

25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.

Fed Circ sides with Axonics in patent validity battle

8 August 2023 US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.

More on this story

Fed Circ sides with Axonics in patent validity battle

8 August 2023 US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.

Split Fed Cir refutes Medtronic challenge to catheter patents

25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.

Medtronic unit to pay $106.5 million in heart valve feud

9 February 2023 Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid.

More on this story

Fed Circ sides with Axonics in patent validity battle

8 August 2023 US Court of Appeals highlights procedural rules in patent dispute concerning medical device charging patents | Medtronic now faces further patent validity reviews after Fed Circ rules in favour of rival.

Split Fed Cir refutes Medtronic challenge to catheter patents

25 May 2023 Medtronic prior art reference does not qualify, says Federal Circuit | Firm was hoping to invalidate five catheter technology patents.

Medtronic unit to pay $106.5 million in heart valve feud

9 February 2023 Jury rules that a medical device infringes a pair of Colibri patents | Medtronic fails to prove patent was invalid.

More features

Bayer gains exclusive licence for heart drug in Japan

EPO delivers key Novo Nordisk, GSK and Inhibrx rulings

McGuireWoods expands team with ex-Novo Nordisk GC

Paul, Weiss swoops for senior duo from Weil, Gotshal

UPC bans Meril Life Sciences from selling infringing heart valve

SCOTUS denies Alvogen unit's appeal to sell Bausch Xifaxan generic

Kathi Vidal to rejoin previous firm as partner following USPTO departure

GSK triumphs in EPO appeal, revoking Pfizer patent